GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
8SIQ | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
8SIQ | 8SIQ | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
8SIE | A0A8D0Z6H8 | Pendrin in complex with bicarbonate | |
8SID | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
8SID | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
8SID | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
8SID | 8SID | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
8SIC | 8SIC | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
8SIC | P03200 | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
8SI9 | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
8SI9 | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
8SI9 | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
8SI9 | 8SI9 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
8SGW | A0A8D0Z6H8 | Pendrin in complex with chloride | |
8SGU | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain | |
8SGO | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate | |
8SGO | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate | |
8SGO | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate | |
8SGO | 8SGO | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate | |
8SGN | P03200 | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy651H02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
8SGN | 8SGN | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy651H02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
8SGM | P15813 | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
8SGM | P61769 | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
8SGM | 8SGM | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
8SGB | P15813 | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
8SGB | P61769 | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
8SGB | 8SGB | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
8SGA | 8SGA | Crystal structure of 770E11, a monoclonal antibody isolated from a human Epstein-Barr virus seropositive donor | |
8SDH | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 | |
8SDH | 8SDH | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 | |
8SDG | 8SDG | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43 | |
8SDG | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43 | |
8SDF | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 | |
8SDF | 8SDF | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 | |
8SDB | P07762 | Crystal Structure of E.Coli Branching Enzyme in complex with malto-octose | |
8SD4 | P03452 | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with small molecule fusion inhibitor compound 7 | |
8SD2 | P03452 | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with small molecule fusion inhibitor compound 4 | |
8SBU | P0AEX9 | Crystal structure of MBP fusion with HPPK from Methanocaldococcus jannaschii | |
8SBU | Q59028 | Crystal structure of MBP fusion with HPPK from Methanocaldococcus jannaschii | |
8SB5 | A0A1W6IPB2 | CryoEM structure of DH270.I1.6-CH848.10.17 | |
8SB5 | 8SB5 | CryoEM structure of DH270.I1.6-CH848.10.17 | |
8SB4 | A0A1W6IPB2 | CryoEM structure of DH270.1-CH848.10.17 | |
8SB4 | 8SB4 | CryoEM structure of DH270.1-CH848.10.17 | |
8SB3 | A0A1W6IPB2 | CryoEM structure of DH270.2-CH848.10.17 | |
8SB3 | 8SB3 | CryoEM structure of DH270.2-CH848.10.17 | |
8SB2 | A0A1W6IPB2 | CryoEM structure of DH270.I2-CH848.10.17 | |
8SB2 | 8SB2 | CryoEM structure of DH270.I2-CH848.10.17 | |
8SB1 | A0A1W6IPB2 | CryoEM structure of DH270.I3-CH848.10.17 | |
8SB1 | 8SB1 | CryoEM structure of DH270.I3-CH848.10.17 | |
8SB0 | A0A1W6IPB2 | CryoEM structure of DH270.I4.6-CH848.10.17 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024